The SELEX Assay – Beyond The Right Track

Why has the systematic evolution of ligands by exponential enrichment (SELEX) become so unpopular? What is the reason why everybody puts much more resources on peptide and antibody based drugs rather than small RNA or small DNA aptamers?

We strongly believe there´s a way back on the right track. The Altermune project shows in the right direction.

All the best for a lovely weekend, your team.

This entry was posted in Binding Assay Blog History and tagged , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *



You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>